Recent data indicates that retatrutide, a innovative medication, could represent a considerable improvement in weight management. This treatment combines the properties of a GLP-1 agonist and a GIP receptor , possibly offering a greater impact than current solutions. Clinical trials have shown positive outcomes, including significant reductions in